Susquehanna International Group
AEMD icon

Susquehanna International Group’s Aethlon Medical AEMD Stock Holding History

Susquehanna International Group’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-458
Closed -$18.3K – 11865
2024
Q2 		$18.3K Buy
+458
New +$36.1K ﹤0.01% 11684
2023
Q3 		– Sell
-16
Closed -$4.65K – 11927
2023
Q2 		$4.65K Buy
+16
New +$4.68K ﹤0.01% 11833
2023
Q1 		– Sell
-61
Closed -$13.3K – 12466
2022
Q4 		$13.3K Buy
+61
New +$22.2K ﹤0.01% 11878
2022
Q2 		– Sell
-15
Closed -$17K – 12783
2022
Q1 		$17K Sell
15
-26
-63% -$31K ﹤0.01% 12660
2021
Q4 		$61K Buy
+41
New +$93.4K ﹤0.01% 12443
2020
Q2 		– Sell
-13
Closed -$15K – 10039
2020
Q1 		$15K Buy
+13
New +$22K ﹤0.01% 9986
2019
Q3 		– Sell
-2
Closed -$9K – 10088
2019
Q2 		$9K Buy
+2
New +$13.4K ﹤0.01% 10083
2018
Q3 		– Sell
-4
Closed -$66K – 9110
2018
Q2 		$66K Buy
+4
New +$62.7K ﹤0.01% 9194

Other funds holding AEMD

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's AEMD Position: Q3 2024 in Review

Susquehanna International Group sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 458 shares — an estimated $18.3K sold.

Susquehanna International Group first reported a position in AEMD in Q2 2018 and held it in 8 quarters. The position peaked at $66K in Q2 2018. 15 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

  • Susquehanna International Group reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 458 Aethlon Medical shares in Q3 2024, an estimated $18.3K.
  • Susquehanna International Group first reported a position in Aethlon Medical in Q2 2018 and held it in 8 quarters.
  • Susquehanna International Group's Aethlon Medical position peaked at $66K in Q2 2018.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.